Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas.

MLA

Watson, Juliana, et al. “Long-Term Outcome of Stereotactic Brachytherapy with Temporary Iodine-125 Seeds in Patients with WHO Grade II Gliomas.” Radiation Oncology, vol. 15, no. 1, Dec. 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13014-020-01719-9.

APA

Watson, J., Romagna, A., Ballhausen, H., Niyazi, M., Lietke, S., Siller, S., Belka, C., Thon, N., & Nachbichler, S. B. (2020). Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas. Radiation Oncology, 15(1), 1–10. https://doi.org/10.1186/s13014-020-01719-9

Chicago

Watson, Juliana, Alexander Romagna, Hendrik Ballhausen, Maximilian Niyazi, Stefanie Lietke, Sebastian Siller, Claus Belka, Niklas Thon, and Silke Birgit Nachbichler. 2020. “Long-Term Outcome of Stereotactic Brachytherapy with Temporary Iodine-125 Seeds in Patients with WHO Grade II Gliomas.” Radiation Oncology 15 (1): 1–10. doi:10.1186/s13014-020-01719-9.